Drug Of Abuse Testing Services Market Analysis Report By Drug Type, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global drug of abuse testing services market was prized by USD 2.6 billion in 2020. It is estimated to witness 5.2% CAGR from 2021 to 2028.

Drivers

The growth in the utilization of illegal drugs in addition to the alcohol has produced the extraordinary development of the market for the drug of abuse testing services. The augmentation in government inventiveness to check and battle with substance mistreatment is, furthermore, considerably inspiring the market. A variety of government programs to supervise as well as struggle with substance maltreatment are the factors, stirring the drug of abuse testing services market.

The testing for toxicology is carried out by the private as well as public units, as per the law. The legal authorities contain the right to consent toxicology checking, in addition to describe the circumstances beneath which the examination should be completed. But, there are restrictions that are resolved by means of the court cases.

Alcohol and drug mistreatment between the staff is dangerous for each company. With the intention of abolish such possibility, companies carry out drug of abuse testing plans. But, this can be measured as a breach of human privacy rights. Testing for the drug is conditional on confidentiality legislation, in several nations. There are various standards or criteria, on the basis of which these tests can be performed and breaching them is measured as infringement of an individual’s constitutional rights.

Drug Type Insight

On the basis of drug type, the market is bifurcated into LSD, opioid, cannabis/marijuana, amphetamine & methamphetamine, cocaine, alcohol, plus others.

The cannabis/marijuana section held 26.0% share of the general drug of abuse testing services market, in 2020. This can be credited to the actuality that the cannabis or marijuana is the most usually utilized illegal drug, all over the world.

Consistent with the Substance Abuse and Mental Health Services Administration, the most frequently consumed illegal drug in the U.S. was marijuana, in 2018. This was consumed by roughly 43.5 million citizens.

In 2020, the opioids section held the subsequent major share. This can be credited to the rising opioid calamity in major sections, for example Europe and North America.

As stated by the information published by the National Center for Drug Abuse Statistics, approximately 2 million citizens in the U.S. possessed opioid use complaints, in 2018. It includes medicine pain reliever as well as heroin maltreatment. Moreover, major companies of the market are taking on the policy for natural enlargement, to increase their opioids testing range.

Regional Insight

North America held the major, 39.1% share of the drug of abuse testing services market in 2020, mainly on account of the existence of major companies, taking on the wide-ranging growth policy. Moreover, its leading share can be credited to the rising occurrences of matter maltreatment within the state plus government lead to restrain it.

Besides, an augmented percentage of substance use complaints, caused by the Covid-19 pandemic, are expected to increase the demand for the drug of abuse testing services, within the region.

But the lockdowns implemented on a national scale, because of the Covid-19 pandemic, are projected to decrease the requirement for the workplace drug testing services, consequently producing lethargic development of the market.

Asia Pacific is expected to observe well-paid enlargement, during the forecast period, because of the increasing demand for the substance abuse testing services from budding nations like India and China. The rising commonness of the substance abuse complaints in major Asia Pacific nations along with the incessant programs taken on by the authoritarian organizations to administer it is likely to impel the section throughout the forecast period.

On the other hand, the need of obvious rules, associated to workplace drug testing, along with countrywide lockdowns caused by the Covid-19 pandemic are expected to be the most important factors, impeding expansion of the market.

Companies

The major companies implement dissimilar policies, intended for the enlargement, for example geographical growth, development for the innovative product, and policy of product differentiation, to take over the large market shares.

Some of the companies for drug of abuse testing services market are:

• United States Drug Testing Laboratories (USDTL), Inc.
• Precision Diagnostics
• Millennium Health
• Omega Laboratories, Inc.
• Legacy Medical Services
• Laboratory Corporation of America Holdings
• Abbott Laboratories
• LGC Group
• American Substance Abuse Professionals (ASAP), Inc.
• Mayo Clinic Laboratories
• Psychemedics Corporation
• Drug Scan
• Cord ant Health Solutions
• Clinical Reference Laboratory (CRL), Inc.
• Quest Diagnostics

Report Scope 

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Million Insights has segmented the global drug of abuse testing services market report on the basis of drug type and region:

• Drug Type Outlook (Revenue, USD Million, 2016 - 2028)
    • Alcohol
    • Cannabis/Marijuana
    • Cocaine
    • Opioids
    • Amphetamine & Methamphetamine
    • LSD
    • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
    • Asia Pacific
        • Japan
        • China
        • India
    • Latin America
        • Brazil
        • Mexico
        • Chile
    • MEA
        • South Africa
        • Saudi Arabia
        • UAE